Polypharmacy and inappropriate medication use are very common in multimorbid older patients. This population has unfortunately been excluded from most large, randomized studies. In a recent multicenter randomized study (OPERAM), we included over 2000 multimorbid patients. We found that 86% of the patients aged 70 years and more had inappropriate medications and that these medications could be discontinued without negative impact on the health of these patients. This cohort of multimorbid patients will be followed for 10 years to evaluate their prognosis, life expectancy, treatments and quality of life, with numerous projects to better understand the inappropriate prescribing of individual drugs and their consequences on the health of this population.
Polypharmacy and inappropriate medications in multimorbid elderly patients What OPERAM taught us and will teach us / Bretagne, L.; Jungo, K. T.; Blum, M. R.; Schwenkglenks, M.; Chiolero, A.; Del Giovane, C.; Gencer, B.; Aujesky, D.; Rodondi, N.. - In: REVUE MÉDICALE SUISSE. - ISSN 1660-9379. - 18:772(2022), pp. 427-432. [10.53738/REVMED.2022.18.772.427]
Polypharmacy and inappropriate medications in multimorbid elderly patients What OPERAM taught us and will teach us
Del Giovane C.;
2022
Abstract
Polypharmacy and inappropriate medication use are very common in multimorbid older patients. This population has unfortunately been excluded from most large, randomized studies. In a recent multicenter randomized study (OPERAM), we included over 2000 multimorbid patients. We found that 86% of the patients aged 70 years and more had inappropriate medications and that these medications could be discontinued without negative impact on the health of these patients. This cohort of multimorbid patients will be followed for 10 years to evaluate their prognosis, life expectancy, treatments and quality of life, with numerous projects to better understand the inappropriate prescribing of individual drugs and their consequences on the health of this population.Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris